Are There Any Risks Associated with Targeting Chromosomal Instability?
While targeting CIN holds promise, it also presents risks. Normal cells can sometimes be affected by therapies aimed at exploiting CIN, leading to unwanted side effects. Furthermore, the genetic diversity generated by CIN can lead to the emergence of resistant cancer cell clones, necessitating combination therapies to effectively manage the disease.
